| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Endocrinology (E.R.), University of Milan, 20133 Milan, Italy; Section of Endocrinology (R.R., G.T., F.B., M.R.A., E.C.d.U.), Department of Biochemical Sciences and Advanced Therapies, University of Ferrara, 44100 Ferrara, Italy; Radiotherapy Department (L.B.), Malpighi Hospital, 40100 Bologna, Italy; and Section of Endocrinology, Diabetes, and Nutrition (E.N.P., L.E.B.), Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts 02118
Address all correspondence and requests for reprints to: Elizabeth N. Pearce, M.D., M.Sc., Section of Endocrinology, Diabetes, and Nutrition, Boston Medical Center, 88 East Newton Street, Evans 201, Boston, Massachusetts 02118. E-mail: elizabeth.pearce{at}bmc.org.
Context: The recognition of thyroid microcarcinoma has increased due to the widespread use of ultrasound-guided fine-needle aspiration biopsies.
Objective: The objective of this study was to describe histological and clinical characteristics of papillary thyroid microcarcinoma (PTMC) less than or equal to 1 cm.
Design: This study was a retrospective cohort.
Setting: This study was conducted at a university hospital endocrine clinic.
Patients: Over a 9-yr period, 243 consecutive patients with PTMC were studied.
Results: PTMC was an incidental finding at surgery in 21.4% of the PTMC cases. There were no differences in the clinical characteristics between those with incidental PTMC and those with suspected thyroid carcinoma. None of the patients with a cancer less than 8 mm had distant metastases, whereas distant metastases were observed in patients with cancers
8 mm (P
0.05). Disease-related mortality was not observed.
Conclusions: PTMC is prevalent in the population. Among patients with PTMC, tumor size more than 8 mm is associated with more aggressive disease.
This article has been cited by other articles:
![]() |
F Palos-Paz, O Perez-Guerra, J Cameselle-Teijeiro, C Rueda-Chimeno, F Barreiro-Morandeira, J Lado-Abeal, the Galician Group for the Study of Toxic Multinod, D Araujo Vilar, R Argueso, O Barca, et al. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain Eur. J. Endocrinol., November 1, 2008; 159(5): 623 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Gharib, E Papini, and R Paschke Thyroid nodules: a review of current guidelines, practices, and prospects Eur. J. Endocrinol., November 1, 2008; 159(5): 493 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wong-You-Cheong Invited Commentary RadioGraphics, November 1, 2008; 28(7): 1887 - 1889. [Full Text] [PDF] |
||||
![]() |
L. Brunese, A. Romeo, S. Iorio, G. Napolitano, S. Fucili, P. Zeppa, G. Vallone, G. Lombardi, A. Bellastella, B. Biondi, et al. Thyroid B-flow twinkling sign: a new feature of papillary cancer Eur. J. Endocrinol., October 1, 2008; 159(4): 447 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-D. Lin, S.-F. Kuo, T.-C. Chao, and C. Hsueh Incidental and Nonincidental Papillary Thyroid Microcarcinoma Ann. Surg. Oncol., August 1, 2008; 15(8): 2287 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brunese, A. Romeo, S. Iorio, G. Napolitano, S. Fucili, B. Biondi, G. Vallone, and A. Sodano A New Marker for Diagnosis of Thyroid Papillary Cancer: B-Flow Twinkling Sign J. Ultrasound Med., August 1, 2008; 27(8): 1187 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. McCartney and G. J. Stukenborg Decision Analysis of Discordant Thyroid Nodule Biopsy Guideline Criteria J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3037 - 3044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Kim, C. H. Lee, S. Y. Kim, W. K. Jeon, J. H. Kang, S. K. An, and W. S. Jun Radiologic and Pathologic Findings of Nonpalpable Thyroid Carcinomas Detected by Ultrasonography in a Medical Screening Center J. Ultrasound Med., February 1, 2008; 27(2): 215 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Burman Micropapillary Thyroid Cancer: Should We Aspirate All Nodules Regardless of Size? J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2043 - 2046. [Full Text] [PDF] |
||||
![]() |
E. L. Mazzaferri Managing small thyroid cancers. JAMA, May 10, 2006; 295(18): 2179 - 2182. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |